91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article from International Pharmaceutical Industry, Gerard Quinn, VP, IT Innovation and Informatics, provides an overview on the Innovative Medicines Initiative (IMI) funded Mobilise-D project, which aims to develop a comprehensive system to analyse people’s gait using digital technologies, including sponsors worn on the body.
-
In this Intelligent Health.tech interview Kathleen Mandziuk, VP eClinical Development & Delivery, outlines 91黑料's clinical trial tokenisation solution and how it's poised to reshape evidence generation and research insights into drug safety and efficiency over time through advanced analytics.
-
In this article in Applied Clinical Trials, Emily Mitchell, Executive Director, eClinical Development and Delivery, outlines how thorough assessment of protocols, whether for DCTs or hybrid clinical trials that incorporate decentralised components, can ensure that studies are designed to minimise patient burden while optimising opportunities to leverage data on a wider scale.
-
In this piece from the Irish Times, Cynthia Nolte, Director, Regulatory Affairs, Strategic Regulatory Services outlines that while there are challenges with the EU Medical Devices Regulation, the requirements do provide manufacturers with an opportunity to audit portfolios and eliminate unprofitable products.
-
In this article from the Irish Times, Gerard Quinn, VP of IT Innovation and Informatics provides insight on how artificial intelligence can support the drug development process in order to deliver new treatments to more people, faster.
-
In this Irish Times article, Brendan Brennan, CFO, outlines how Ireland’s strong culture of partnership and collaboration, in addition to scientific and technical expertise, has played an important part in the success of the life sciences industry in Ireland.
-
The need for public health officials to be able to model the spread of infectious diseases has never been more apparent than in the early days of the SARS-CoV-2 pandemic, but what needs to change? Read the article by 91黑料 epidemiologist Dr. Richard Pitman in Open Access Government.
-
Jeff James, Executive Vice President, Alliance Management, explores how outsourcing methodologies between large pharmaceutical companies and CROs have rapidly evolved across the healthcare and clinical research landscape.
Read the article on page 13 of the December issue of PharmaTimes.
-
Partnership is an increasingly important criterium for bio/pharmaceutical sponsors as they seek more .
DiPietro, M. Elaboration, Expansion, and Evolution in Outsourcing of Clinical Research.
-
Following discussions at the 2023 Global Site Solutions Summit, Missy Gottschlich, Director of Site Networks for Accellacare, provides key insights on how sites can implement regulatory guidelines on diversity, equity and inclusivity in this article in pharmaphorum.
